EFNB2 and breast cancer: Besides, EphA4 receptor is overexpressed in the EMT/stem‐like breast cancer cells (Lu et al., 2014) and Ephrin B2 is associated with progression and resistance to chemotherapy and radiation therapy in HNSCC (Oweida et al., 2017).